نتائج البحث - Favre‐Guilmard, Christine
- يعرض 1 - 4 نتائج من 4
-
1
Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems حسب Elliott, Mark, Maignel, Jacquie, Liu, Sai Man, Favre-Guilmard, Christine, Mir, Imran, Farrow, Paul, Hornby, Fraser, Marlin, Sandra, Palan, Shilpa, Beard, Matthew, Krupp, Johannes
منشور في 2017نص -
2
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo حسب Donald, Sarah, Elliott, Mark, Gray, Bryony, Hornby, Fraser, Lewandowska, Agnieszka, Marlin, Sandra, Favre‐Guilmard, Christine, Périer, Cindy, Cornet, Sylvie, Kalinichev, Mikhail, Krupp, Johannes, Fonfria, Elena
منشور في 2018نص -
3
Recombinant botulinum neurotoxin serotype A1 in vivo characterization حسب Périer, Cindy, Martin, Vincent, Cornet, Sylvie, Favre‐Guilmard, Christine, Rocher, Marie‐Noelle, Bindler, Julien, Wagner, Stéphanie, Andriambeloson, Emile, Rudkin, Brian, Marty, Rudy, Vignaud, Alban, Beard, Matthew, Lezmi, Stephane, Kalinichev, Mikhail
منشور في 2021نص -
4
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models حسب Elliott, Mark, Favre-Guilmard, Christine, Liu, Sai Man, Maignel, Jacquie, Masuyer, Geoffrey, Beard, Matthew, Boone, Christopher, Carré, Denis, Kalinichev, Mikhail, Lezmi, Stephane, Mir, Imran, Nicoleau, Camille, Palan, Shilpa, Perier, Cindy, Raban, Elsa, Zhang, Sicai, Dong, Min, Stenmark, Pål, Krupp, Johannes
منشور في 2019نص